Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Glufosfamide begins phase I study in Japan

Jan. 18, 2007

FDA awards orphan drug status to Marqibo for ALL

Jan. 18, 2007

Fodosine begins pivotal study for relapsed or refractory T-cell leukemia/lymphoma

Jan. 18, 2007

Novel DPP II inhibitor characterized at ActivX

Jan. 18, 2007

Novel treatments for cancer covered in recent patent literature

Jan. 18, 2007

Cleveland BioLabs enters research partnership with Roswell Park Cancer Institute

Jan. 17, 2007

Third interim analysis due in pivotal breast cancer study of tesmilifene

Jan. 17, 2007

Promising preclinical results with raloxifene-derived selective estrogen receptor modulator

Jan. 16, 2007

Metastatic pancreatic cancer patients show clinical responses to talabostat therapy

Jan. 16, 2007

Progress in phase I study of anticancer compound ECO-4601

Jan. 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...